fMRI Lie-Detection, Pay-to-Delay Settlements, Enhancement Technologies.
Listen now
Description
Hank Greely, Jake Sherkow, and Matt Lamkin discuss fMRI lie-detection services, pay-to-delay settlements between branded pharmaceutical and generics companies, and the arguments against increased regulation of enhancement technologies.
More Episodes
Hank Greely, Patti Zettler, Dmitry Karshtedt, and Stephanie Bair discuss new developments related to the Biosimilars Act and FDA's orphan drug program, the policy implications of brain myths, and the current Ebola crisis.
Published 10/21/14
Anna Laakman from Lewis and Clark law school discusses her recent work with Hank Greely.
Published 10/07/14